BIOMAT Database Logo BIOMAT Database Logo

Hepatitis B x antigen and polymerase antibodies in the serum of hepatitis B carriers with or without hepatitis delta virus infection. Effects of interferon treatment. 1992

L Lega, and A Vierucci, and B S Blumberg, and G Saracco, and M Rizzetto, and M Zhu, and M A Feitelson
Department of Pediatrics, University of Florence, Italy.

Previous work has shown that the hepatitis B x antigen (HBxAg) and antibodies directed against the polymerase of hepatitis B virus (anti-pol) are early markers of hepatitis B virus (HBV) replication in natural infections. The present study was carried out to test the hypothesis that the appearance of one or both of these markers signaled reactivation in chronic carriers with liver disease who were treated with alpha-interferon (IFN). The results show that HBV DNA decreased among the patients who responded to therapy, and that among these responders, neither HBxAg nor anti-pol became detectable in serum for 12 months after treatment, in contrast to controls. Hence, the loss of HBxAg and anti-pol correlate with decreased levels of HBV DNA in response to IFN therapy. However, different patterns of HBxAg and anti-pol were observed among alpha-IFN-treated HBV carrier patients who were also chronically infected with the hepatitis delta virus (HDV). The treatment of such patients often resulted in the loss of HDV RNA from serum and delta antigen from liver. Most of these patients had increased levels of HBV DNA in serum. HBxAg and/or anti-pol also became detectable in patients who lost markers of HDV, implying that the suppression of HDV by IFN is accompanied by the appearance of early markers of HBV reactivation in some of the treated patients.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D003699 Hepatitis D INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Amazon Black Fever,Black Fever, Amazon,Delta Hepatitis,Delta Infection,Delta Superinfection,Hepatitis, Delta,Labrea Disease,Infection, Delta,Superinfection, Delta,Delta Superinfections,Disease, Labrea,Diseases, Labrea,Fever, Amazon Black,Hepatitides, Delta,Infections, Delta,Labrea Diseases,Superinfections, Delta
D004259 DNA-Directed DNA Polymerase DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. DNA Polymerase,DNA Polymerases,DNA-Dependent DNA Polymerases,DNA Polymerase N3,DNA Dependent DNA Polymerases,DNA Directed DNA Polymerase,DNA Polymerase, DNA-Directed,DNA Polymerases, DNA-Dependent,Polymerase N3, DNA,Polymerase, DNA,Polymerase, DNA-Directed DNA,Polymerases, DNA,Polymerases, DNA-Dependent DNA
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti

Related Publications

L Lega, and A Vierucci, and B S Blumberg, and G Saracco, and M Rizzetto, and M Zhu, and M A Feitelson
Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection.
December 1991, The Journal of infectious diseases,
L Lega, and A Vierucci, and B S Blumberg, and G Saracco, and M Rizzetto, and M Zhu, and M A Feitelson
Hepatitis delta virus antibodies in hepatitis B surface antigen asymptomatic carriers in Senegal.
January 1990, The Journal of infectious diseases,
L Lega, and A Vierucci, and B S Blumberg, and G Saracco, and M Rizzetto, and M Zhu, and M A Feitelson
[Hepatitis delta virus infection in asymptomatic carriers of the hepatitis B virus].
September 1989, Anales de medicina interna (Madrid, Spain : 1984),
L Lega, and A Vierucci, and B S Blumberg, and G Saracco, and M Rizzetto, and M Zhu, and M A Feitelson
Assessment of hepatitis B virus DNA levels in chronic HBsAg carriers with or without hepatitis delta virus superinfection.
April 1988, Journal of hepatology,
L Lega, and A Vierucci, and B S Blumberg, and G Saracco, and M Rizzetto, and M Zhu, and M A Feitelson
Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.
November 1979, Lancet (London, England),
L Lega, and A Vierucci, and B S Blumberg, and G Saracco, and M Rizzetto, and M Zhu, and M A Feitelson
Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies.
August 2001, Liver,
L Lega, and A Vierucci, and B S Blumberg, and G Saracco, and M Rizzetto, and M Zhu, and M A Feitelson
Delta infection in asymptomatic carriers of hepatitis B surface antigen: low prevalence of delta activity and effective suppression of hepatitis B virus replication.
January 1988, Hepatology (Baltimore, Md.),
L Lega, and A Vierucci, and B S Blumberg, and G Saracco, and M Rizzetto, and M Zhu, and M A Feitelson
Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers.
January 1985, Hepatology (Baltimore, Md.),
L Lega, and A Vierucci, and B S Blumberg, and G Saracco, and M Rizzetto, and M Zhu, and M A Feitelson
Prevalence of infection with hepatitis delta virus (HDV) among carriers of hepatitis B surface antigen in Amazonas State, Brazil.
January 1988, Transactions of the Royal Society of Tropical Medicine and Hygiene,
L Lega, and A Vierucci, and B S Blumberg, and G Saracco, and M Rizzetto, and M Zhu, and M A Feitelson
Serum hepatitis B virus-DNA in chronic hepatitis B and delta infection.
May 1985, Archives of pathology & laboratory medicine,
Copied contents to your clipboard!